Latest Breaking News On - Vamsi kota - Page 1 : comparemela.com
Savannah patient got Georgia Cancer Center 1,000th stem cell transplant
augustachronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from augustachronicle.com Daily Mail and Mail on Sunday newspapers.
Cancer and chemotherapy won t deter Paralympian from competing
augustachronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from augustachronicle.com Daily Mail and Mail on Sunday newspapers.
Large Gene panel helpful in identifying cancer-causing genes ANI | Updated: Feb 06, 2021 14:14 IST
Washington [US], February 6 (ANI): Researchers during a recent study have found a gene panel that includes all genes known to potentially cause cancer. This can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML.
The 523-gene panel, which looks about 10 times the number of cancer-causing genes, developed by San Diego-based biotech company Illumina, is currently used to diagnose and fine-tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia. The investigators reported in the journal PLOS ONE.
Credit: Kim Ratliff, Augusta University Photographer
AUGUSTA, Ga. (Feb. 1, 2020) - A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.
The 523-gene panel, developed by San Diego-based biotech company Illumina, which includes all genes known to potentially cause cancer, can be readily adopted for use in clinical laboratories to diagnose acute myeloid leukemia, or AML, the investigators report in the journal
PLOS ONE.
Identifying more genetic mutations in an individual s cancer also enables more targeted treatment for that patient, they say. That includes finding mutations not previously associated with their cancer type, which opens the door to using drugs targeting those mutations that have traditionally been used against other cancers.